However, there remains the fact that, despite the different
strategies adopted, it is virtually impossible to safeguard the
blood supply from malaria in endemic countries [10,11], and
often the transfusion of blood, together with the judicial use
of antimalarial drugs, is necessary to minimize the occur-rence of TTM in the recipient. In addition, promoting the
appropriate clinical use of blood also has a role in minimizing
TTM, by ensuring that patients are not exposed unnecessarily.